The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
xin shu ke li dui guan xin bing he bing yi yu zheng bing ren xin lv bian yi xing ji chao min c- fan ying dan bai de ying xiang
Author(s): 
Pages: 637-638
Year: Issue:  6
Journal: Research of Traditional Chinese Medicine

Keyword:  欣舒颗粒冠心病抑郁症心率变异性超敏C反应蛋白;
Abstract: 目的观察欣舒颗粒对冠心病合并抑郁症病人心率变异性(HRV)及其对超敏C反应蛋白(hs-CRP)的影响,并探讨其作用机制。方法40例冠心病合并抑郁症病人随机分成两组,研究组20例,在常规西医冠心病二级预防治疗的基础上,加用欣舒颗粒冲服,对照组仅予以西医冠心病二级预防治疗。分别于治疗前和治疗2周后观察两组病人24 h HRV、hs-CRP等指标的变化。结果两组治疗后HRV、hs-CRP水平较治疗前明显改善(P<0.05),且研究组优于对照组(P<0.05)。结论欣舒颗粒可显著改善冠心病合并抑郁症病人的HRV,抑制炎症反应,提高冠心病疗效。
Related Articles
No related articles found